Total Payments
$110,140
2024 Payments
$5,008
Companies
12
Transactions
214
Medicare Patients
7,075
Medicare Billing
$571,080
Payment Breakdown by Category
Other$82,500 (74.9%)
Travel$11,792 (10.7%)
Consulting$11,100 (10.1%)
Food & Beverage$4,659 (4.2%)
Education$89.00 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $82,500 | 26 | 74.9% |
| Travel and Lodging | $11,792 | 39 | 10.7% |
| Consulting Fee | $11,100 | 5 | 10.1% |
| Food and Beverage | $4,659 | 143 | 4.2% |
| Education | $89.00 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Galderma Laboratories, L.P. | $88,085 | 119 | $0 (2024) |
| Allergan, Inc. | $21,213 | 59 | $0 (2022) |
| ABBVIE INC. | $367.00 | 18 | $0 (2024) |
| Janssen Biotech, Inc. | $107.19 | 2 | $0 (2021) |
| GENZYME CORPORATION | $103.76 | 6 | $0 (2024) |
| REVANCE THERAPEUTICS, INC. | $94.98 | 1 | $0 (2024) |
| Sun Pharmaceutical Industries Inc. | $81.52 | 4 | $0 (2023) |
| LEO Pharma Inc. | $23.79 | 1 | $0 (2022) |
| Lilly USA, LLC | $21.31 | 1 | $0 (2023) |
| EPI Health, LLC | $17.53 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,008 | 24 | Galderma Laboratories, L.P. ($4,535) |
| 2023 | $10,611 | 7 | Galderma Laboratories, L.P. ($10,523) |
| 2022 | $24,118 | 36 | Galderma Laboratories, L.P. ($23,866) |
| 2021 | $7,682 | 21 | Galderma Laboratories, L.P. ($7,382) |
| 2020 | $7,157 | 10 | Galderma Laboratories, L.P. ($6,601) |
| 2019 | $21,292 | 45 | Allergan Inc. ($12,378) |
| 2018 | $19,803 | 37 | Galderma Laboratories, L.P. ($16,582) |
| 2017 | $14,469 | 34 | Galderma Laboratories, L.P. ($9,739) |
All Payment Transactions
214 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/21/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $94.98 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 11/20/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $6.67 | General |
| Category: FACIAL AESTHETICS | ||||||
| 11/19/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $19.08 | General |
| 11/05/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $1.97 | General |
| Category: FACIAL AESTHETICS | ||||||
| 10/17/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $12.68 | General |
| 10/17/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $4.90 | General |
| 09/24/2024 | Galderma Laboratories, L.P. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,500.00 | General |
| 09/20/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: FACIAL AESTHETICS | ||||||
| 09/16/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $15.30 | General |
| 09/10/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $20.77 | General |
| 08/29/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: Immunology | ||||||
| 08/19/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $19.60 | General |
| 08/01/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: Immunology | ||||||
| 07/17/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: Immunology | ||||||
| 06/20/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: Immunology | ||||||
| 06/04/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $15.31 | General |
| Category: Immunology | ||||||
| 03/05/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $10.73 | General |
| Category: FACIAL AESTHETICS | ||||||
| 03/05/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $10.73 | General |
| Category: FACIAL AESTHETICS | ||||||
| 02/20/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: FACIAL AESTHETICS | ||||||
| 02/20/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: FACIAL AESTHETICS | ||||||
| 02/14/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $33.21 | General |
| Category: FACIAL AESTHETICS | ||||||
| 02/06/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: FACIAL AESTHETICS | ||||||
| 02/06/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: FACIAL AESTHETICS | ||||||
| 01/10/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $105.00 | General |
| Category: FACIAL AESTHETICS | ||||||
| 09/12/2023 | AbbVie Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: FACIAL AESTHETICS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 31 | 2,377 | 4,703 | $429,469 | $188,207 |
| 2022 | 29 | 1,767 | 3,740 | $351,446 | $152,362 |
| 2021 | 28 | 1,560 | 3,209 | $267,709 | $128,650 |
| 2020 | 21 | 1,371 | 2,979 | $213,970 | $101,861 |
Total Patients
7,075
Total Services
14,631
Medicare Billing
$571,080
Procedure Codes
109
All Medicare Procedures & Services
109 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 336 | 451 | $88,609 | $40,314 | 45.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 291 | 407 | $56,592 | $26,791 | 47.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 221 | 309 | $53,931 | $23,306 | 43.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 323 | 539 | $55,824 | $20,055 | 35.9% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 171 | 202 | $31,601 | $12,647 | 40.0% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 246 | 1,778 | $17,948 | $9,033 | 50.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 142 | 169 | $14,700 | $6,757 | 46.0% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 32 | 44 | $11,512 | $5,613 | 48.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 55 | 55 | $9,590 | $4,087 | 42.6% |
| 11402 | Removal of noncancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 24 | 29 | $7,753 | $3,642 | 47.0% |
| 11401 | Removal of noncancer skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2023 | 32 | 33 | $8,031 | $3,621 | 45.1% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 22 | 25 | $6,922 | $3,539 | 51.1% |
| 10060 | Simple or single drainage of skin abscess | Office | 2023 | 37 | 39 | $7,575 | $3,502 | 46.2% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2023 | 36 | 38 | $7,168 | $3,136 | 43.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 25 | 25 | $6,439 | $2,782 | 43.2% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 59 | 80 | $7,071 | $2,706 | 38.3% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2023 | 19 | 29 | $5,906 | $2,331 | 39.5% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 51 | 73 | $4,020 | $2,043 | 50.8% |
| 17271 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm | Office | 2023 | 15 | 15 | $3,879 | $1,960 | 50.5% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 36 | 45 | $3,495 | $1,714 | 49.0% |
| 11302 | Shaving of skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 17 | 17 | $3,607 | $1,610 | 44.6% |
| 17281 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 11 | 12 | $3,348 | $1,566 | 46.8% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 15 | 16 | $3,651 | $1,329 | 36.4% |
| 11311 | Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 11 | 11 | $2,325 | $1,096 | 47.1% |
| 11310 | Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.5 cm or less | Office | 2023 | 12 | 13 | $2,350 | $907.22 | 38.6% |
About Dr. David Balle, M.D
Dr. David Balle, M.D is a Dermatology healthcare provider based in Grosse Pointe, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/30/2005. The National Provider Identifier (NPI) number assigned to this provider is 1356334841.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Balle, M.D has received a total of $110,140 in payments from pharmaceutical and medical device companies, with $5,008 received in 2024. These payments were reported across 214 transactions from 12 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($82,500).
As a Medicare-enrolled provider, Balle has provided services to 7,075 Medicare beneficiaries, totaling 14,631 services with total Medicare billing of $571,080. Data is available for 4 years (2020–2023), covering 109 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Grosse Pointe, MI
- Active Since 08/30/2005
- Last Updated 07/08/2007
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1356334841
Products in Payments
- BOTOX COSMETIC (Biological) $8,341
- BOTOX (Biological) $391.66
- DAXXIFY (Drug) $94.98
- TREMFYA (Drug) $89.00
- DUPIXENT (Biological) $80.23
- ILUMYA (Biological) $62.99
- ADBRY (Biological) $23.79
- TALTZ (Drug) $21.31
- Humira (Biological) $21.22
- Winlevi (Drug) $18.53
- Tremfya (Drug) $18.19
- Sitavig (Drug) $17.53
- Enbrel (Biological) $12.23
- Ceracade (Drug) $12.15
- EPIDUO FORTE (Drug) $11.54
- EPIDUO (Drug) $0.61
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.